EU Horizon funding · NACE 86
Horizon Europe funding for healthcare companies
NACE 86 · Human health activities
23 healthcare companies (NACE 86) received €16M in EU research and innovation funding across 37 Horizon Europe and Horizon 2020 projects starting between 2015 and 2026; 81% of the money went to SMEs.
- EU contribution
- €16M
- 2015–2026 project starts
- Funded companies
- 23
- 14 of them SMEs
- Projects
- 37
- Horizon Europe and Horizon 2020
- Share to SMEs
- 81%
- €13M to SMEs
Industry is known only for companies matched to the national business registers in France, Finland, Belgium, Estonia, Sweden and Czech Republic, so this page covers funded private companies from those countries. Companies elsewhere in Europe are counted on the country pages.
In numbers
Healthcare companies (NACE 86) rank 38th of 62 industry divisions by total EU funding received.
Of the total, Horizon 2020 (2014–2020) accounts for €10M across 23 projects and Horizon Europe (2021–2027) for €5.8M across 14 projects.
The strongest start year was 2015, when projects worth €4.9M to these companies began.
The largest funding route was the SME Instrument Phase 2 with €5.6M (35% of the total, 2 projects).
Immunovia AB (publ) (Stockholm) is the largest recipient with €4.2M over 1 project; the 10 largest recipients together received 89% of the total.
The average funded company received €703k; 61% of the companies are SMEs.
By programme
Horizon 2020 2014–2020
€10M
23 projects · 64% of the total
Horizon Europe 2021–2027
€5.8M
14 projects · 36% of the total
Funding by start year
EU contribution to these companies, by the year their project started.
| Year | EU contribution |
|---|---|
| 2015 |
€4.9M
|
| 2016 |
€353k
|
| 2017 |
€592k
|
| 2018 |
€2.3M
|
| 2019 |
€684k
|
| 2020 |
€1.2M
|
| 2021 |
€363k
|
| 2022 |
€2.9M
|
| 2023 |
€1.2M
|
| 2024 |
€21k
|
| 2025 |
€630k
|
| 2026 |
€1.1M
|
2014–2020 starts (mostly Horizon 2020) 2021 onwards (Horizon Europe)
Largest recipients
Companies with the highest EU contribution, Horizon Europe and Horizon 2020 combined.
| # | Company | Programmes | Projects | EU contribution |
|---|---|---|---|---|
| 1 | Immunovia AB (publ) SME Stockholm, Sweden | Horizon 2020 | 1 | €4.2M |
| 2 | BiopSense Oy SME Jyväskylä, Finland | Horizon Europe | 1 | €2.5M |
| 3 | Celvia CC AS SME Tartu, Estonia | Horizon 2020, Horizon Europe | 9 | €2.2M |
| 4 | Coris Bioconcept SME Gembloux, Belgium | Horizon 2020 | 4 | €1.4M |
| 5 | 720 Degrees Oy SME Helsinki, Finland | Horizon 2020 | 1 | €1.4M |
| 6 | Medipath Frejus, France | Horizon Europe | 1 | €785k |
| 7 | Eurofins Amatsigroup Gent, Belgium | Horizon 2020 | 2 | €629k |
| 8 | Unilabs AB Solna, Sweden | Horizon 2020, Horizon Europe | 2 | €452k |
| 9 | Diaverum Sweden AB Malmö, Sweden | Horizon 2020 | 1 | €450k |
| 10 | InnoSer België SME Diepenbeek, Belgium | Horizon Europe | 1 | €376k |
Funding schemes
How the money reached these companies.
-
SME Instrument Phase 2 €5.6M2 projects SME-2 35%
-
Research and Innovation Action (RIA) €4.8M15 projects HORIZON-RIA · RIA 30%
-
EIC Pathfinder & Transition €2.5M1 project HORIZON-EIC 15%
-
Marie Skłodowska-Curie Actions €1.5M10 projects HORIZON-TMA-MSCA-SE · MSCA-ITN · MSCA-ITN-ETN 9%
-
Coordination and Support Action (CSA) €833k2 projects HORIZON-CSA 5%
-
Innovative Medicines Initiative 2 €318k1 project IMI2-RIA 2%
Notable recent projects
Recent projects with the largest EU contribution to these companies. Links open the project on CORDIS.
-
TWIN-X
Multimodal Digital TWINs with Generative AI for eXplainable Precision Medicine
Started 2026 Horizon Europe Research and Innovation Action (RIA) Total EU contribution €15M to these companies €785k
-
NEO-LIFE
Non-invasive Enhanced Omics and AI-Led Insights in Fetal-maternal hEalth
Started 2025 Horizon Europe Marie Skłodowska-Curie Actions Total EU contribution €1.8M to these companies €296k
-
TULIP
Untapping the potential for improved female reproductive healthcare: diagnosing and reinforcing the status of UTERINE-associated fertility
Started 2026 Horizon Europe Marie Skłodowska-Curie Actions Total EU contribution €1.8M to these companies €210k
-
RealiseD
Comprehensive methodological and operational approach to clinical trials in rare and ultra-rare diseases
Started 2025 Horizon Europe Joint Undertaking actions (Horizon Europe) Total EU contribution €8.5M to these companies €178k
-
ERIS
European Research Institute on Simulation
Started 2025 Horizon Europe Coordination and Support Action (CSA) Total EU contribution €1M to these companies €157k
Classes within Healthcare
| Industry (NACE) | Companies | Projects | To SMEs | EU contribution |
|---|---|---|---|---|
| 86.91 Diagnostic Imaging Services and Medical Laboratory | 10 | 20 | 79% |
€7M
|
| 86.22 Medical Specialists | 6 | 6 | 29% |
€1.8M
|
Funding by country
Get company lists in Claude
Ask Claude for companies by industry, size and region, straight from official European business registers, and export the list as CSV.
Source and method
Source: CORDIS – © European Union, 1994–2026, CC BY 4.0. Data modified: aggregated by EU Company Leads. Project and participant data from CORDIS (Horizon Europe and Horizon 2020 project datasets), licensed under CC BY 4.0.
We count organisations that CORDIS lists as private for-profit companies (activity type PRC) with an EU contribution above zero. Amounts are the EU contribution to those companies, not total project budgets; years are project start years. Industries use NACE Rev. 2.1 from the national business registers of France, Finland, Belgium, Estonia, Sweden and Czech Republic and are only known for companies matched to those registers. Figures computed Nov 17, 2026.